⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 14, 2024

[Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].

Jing Yan Dongmei Zhou Xiaoyan Shao Yong Xu Bin Chen

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the prognostic value of the Second Revision of the International Staging System (R2-ISS) in patients with newly diagnosed multiple myeloma (NDMM) .

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yan et al. (2024) studied this question.

synapsesocial.com/papers/68e79403b6db643587704a67 https://doi.org/10.3760/cma.j.cn121090-20230810-00058

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The applicability of the Second Revision of the International Staging System for patients with multiple myeloma receiving immunomodulatory drugs or proteasome inhibitor‐based regimens as induction treatment: A real‐world analysisPrognostic Study · 2022 · 9 citations
2Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation2024 · 9 citations
3Performance of newer myeloma staging systems in a contemporary, large patient cohortCohort Study · 2024 · 5 citations
4Prognostic value of the “dynamic” second revision of the international staging system (R2- ISS) in patients with multiple myeloma undergoing anti-CD38 antibody, carfilzomib, and dexamethasone therapy2024
5Prognostic value of the “dynamic” R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies2024 · 4 citations

R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study2024
The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma2023
Beyond ISS staging: the prognostic value of the Inflammation Prognostic Score Index (IPSI) in multiple myeloma2025

More from Nanjing Medical University

More from Nanjing Drum Tower Hospital